ImmunoPrecise Antibodies Basic EPS 2022-2025 | IPA
ImmunoPrecise Antibodies basic eps from 2022 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| ImmunoPrecise Antibodies Annual Basic EPS | |
|---|---|
| 2024 | $-0.79 |
| 2023 | $-0.80 |
| 2022 | $-0.68 |
| 2021 | $-0.34 |
| ImmunoPrecise Antibodies Quarterly Basic EPS | |
|---|---|
| 2025-01-31 | $-0.46 |
| 2024-10-31 | $-0.07 |
| 2024-07-31 | $-0.11 |
| 2024-04-30 | $-0.53 |
| 2024-01-31 | $-0.08 |
| 2023-10-31 | $-0.07 |
| 2023-07-31 | $-0.11 |
| 2023-04-30 | $-0.14 |
| 2023-01-31 | $-0.14 |
| 2022-10-31 | $-0.23 |
| 2022-07-31 | $-0.30 |
| 2022-04-30 | $-0.18 |
| 2022-01-31 | $-0.16 |
| 2021-10-31 | $-0.21 |
| 2021-07-31 | $-0.14 |
| 2021-04-30 | $-0.23 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.078B | $0.018B |
| ImmunoPrecise Antibodies Ltd. is a technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. ImmunoPrecise Antibodies Ltd. is based in VICTORIA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.605B | 59.29 |
| Hims & Hers Health (HIMS) | United States | $11.194B | 116.30 |
| Doximity (DOCS) | United States | $11.153B | 51.63 |
| Tempus AI (TEM) | United States | $10.574B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.258B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.817B | 59.65 |
| Hinge Health (HNGE) | United States | $3.642B | 0.00 |
| Privia Health (PRVA) | United States | $2.447B | 167.25 |
| Schrodinger (SDGR) | United States | $1.671B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.639B | 0.00 |
| 10x Genomics (TXG) | United States | $1.600B | 0.00 |
| Phreesia (PHR) | United States | $1.595B | 0.00 |
| Enovis (ENOV) | United States | $1.556B | 8.68 |
| Azenta (AZTA) | United States | $1.507B | 70.04 |
| Omnicell (OMCL) | United States | $1.324B | 23.35 |
| Evolent Health (EVH) | United States | $1.147B | 97.70 |
| Claritev (CTEV) | United States | $0.702B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.567B | 0.00 |
| Standard BioTools (LAB) | United States | $0.517B | 0.00 |
| Veradigm (MDRX) | United States | $0.498B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.467B | 0.00 |
| Talkspace (TALK) | United States | $0.435B | 130.00 |
| TruBridge (TBRG) | United States | $0.336B | 745.67 |
| Outset Medical (OM) | United States | $0.336B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.274B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.266B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.229B | 0.00 |
| CapsoVision (CV) | United States | $0.204B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.173B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.158B | 0.00 |
| Pulmonx (LUNG) | United States | $0.130B | 0.00 |
| American Well (AMWL) | United States | $0.128B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.114B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.112B | 0.00 |
| CareCloud (CCLD) | United States | $0.102B | 3.89 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.081B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |